Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study
- PMID: 19789300
- PMCID: PMC2920130
- DOI: 10.1158/1940-6207.CAPR-09-0039
Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study
Abstract
The objective of this study was to examine the association of urinary phytoestrogens with the risk of postmenopausal breast cancer. Participants in the Multiethnic Cohort Study included 36,458 postmenopausal women who provided blood or urine specimens. A nested case-control study of breast cancer with biospecimens was created in which cases diagnosed after specimen collection were matched to two controls. Two hundred fifty-one women with breast cancer and 462 controls had urine available for analysis of urinary phytoestrogens. Odds ratios (OR) and 95% confidence intervals (CI) were obtained using conditional logistic regression. A nonmonotonic inverse trend (P = 0.04) in breast cancer risk was associated with increasing urinary excretion of genistein (OR 25th-75th percentile, 0.88; 95% CI, 0.78-0.99) and total isoflavones (OR 25th-75th percentile, 0.80; 95% CI, 0.65-0.99). A significant reduction in breast cancer risk in Japanese-American women was associated with the highest compared with the lowest quartile excretion of urinary daidzein (OR, 0.41; 95% CI, 0.19-0.89; P(trend), 0.005). The risk of breast cancer was reduced among White women with the highest compared with the lowest quartile excretion of equol (OR, 0.27; 95% CI, 0.08-0.95), although the trend in risk was not significant (P = 0.07). Our results provide some support to the hypothesis that a diet rich in isoflavones from soy products reduces the risk of postmenopausal breast cancer, particularly in populations with comparatively high excretion of phytoestrogens.
Figures
Similar articles
-
Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the Multiethnic Cohort.Br J Cancer. 2009 Jul 7;101(1):185-91. doi: 10.1038/sj.bjc.6605137. Epub 2009 Jun 16. Br J Cancer. 2009. PMID: 19536097 Free PMC article.
-
Urinary phytoestrogens and postmenopausal breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):223-8. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303591
-
Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study.Breast Cancer Res. 2008;10(2):R32. doi: 10.1186/bcr1995. Epub 2008 Apr 17. Breast Cancer Res. 2008. PMID: 18419813 Free PMC article.
-
Plasma phytoestrogens and subsequent breast cancer risk.J Clin Oncol. 2007 Feb 20;25(6):648-55. doi: 10.1200/JCO.2006.06.0244. Epub 2007 Jan 2. J Clin Oncol. 2007. PMID: 17200150
-
Phytoestrogens and breast cancer risk. Review of the epidemiological evidence.Breast Cancer Res Treat. 2003 Jan;77(2):171-83. doi: 10.1023/a:1021381101632. Breast Cancer Res Treat. 2003. PMID: 12602916 Review.
Cited by
-
Health Effects of Soy Isoflavones and Green Tea Catechins on Cancer and Cardiovascular Diseases Based on Urinary Biomarker Levels.Molecules. 2022 Dec 14;27(24):8899. doi: 10.3390/molecules27248899. Molecules. 2022. PMID: 36558031 Free PMC article. Review.
-
Urinary equol levels are positively associated with urinary estradiol excretion in women.Sci Rep. 2021 Sep 30;11(1):19532. doi: 10.1038/s41598-021-98872-2. Sci Rep. 2021. PMID: 34593903 Free PMC article.
-
The Potential Effects of Phytoestrogens: The Role in Neuroprotection.Molecules. 2021 May 16;26(10):2954. doi: 10.3390/molecules26102954. Molecules. 2021. PMID: 34065647 Free PMC article. Review.
-
Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis.Eur J Epidemiol. 2020 Jun;35(6):567-578. doi: 10.1007/s10654-019-00585-4. Epub 2019 Nov 21. Eur J Epidemiol. 2020. PMID: 31754945 Free PMC article.
-
Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production.Nutrients. 2019 Feb 19;11(2):433. doi: 10.3390/nu11020433. Nutrients. 2019. PMID: 30791484 Free PMC article.
References
-
- Peeters PH, Keinan-Boker L, van der Schouw YT, Grobbee DE. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat. 2003;77:171–183. - PubMed
-
- Murphy PA, Song T, Buseman G, et al. Isoflavones in retail and institutional soy foods. J Agric Food Chem. 1999;47:2697–2704. - PubMed
-
- Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer. 1991;16:43–52. - PubMed
-
- Valentín-Blasini L, Sadowski MA, Walden D, Caltabiano L, Needham LL, Barr DB. Urinary phytoestrogen concentrations in the U.S. population (1999–2000) J Expo Anal Environ Epidemiol. 2005;15:509–523. - PubMed
-
- Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med. 1998;217:335–339. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
